Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases and Serum Antibody Changes Post-Omicron Variant Infection

Abstract Introduction The purpose of this study was to investigate whether the inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has a similar effectiveness and safety profile in patients with rheumatic and musculoskeletal diseases (RMDs) and healthy controls (HCs). Me...

詳細記述

書誌詳細

出版年:	Rheumatology and Therapy
主要な著者:	Xiaowei Zhang, Yifei Li, Chunqing Dai, Yaya Chu, Chaoqi Luan, Guihong Wang
フォーマット:	論文
言語:	英語
出版事項:	Adis, Springer Healthcare 2024-01-01
主題:	Rheumatic diseases Musculoskeletal diseases SARS-CoV-2 vaccine Serum antibodies Adverse events Omicron variant
オンライン･アクセス:	https://doi.org/10.1007/s40744-023-00630-5